Intended for healthcare professionals


Brexit: Drug industry pleads for “bare minimum” deal

BMJ 2020; 371 doi: (Published 01 October 2020) Cite this as: BMJ 2020;371:m3845
  1. Adrian O’Dowd
  1. London

Time is running out to secure a post-Brexit trade deal or a “bare minimum” agreement on drugs so as to avoid significant delays to supplies to the UK, MPs have been warned.

Experts from the drug, chemical, and aerospace industries have underlined the potential problems ahead after the end of the Brexit transition period in December if no trade deals are secured between the UK and the EU before then. Representatives of these industries appeared before the House of Commons Committee on the Future Relationship with the European Union during an evidence session for its inquiry held on 30 September .

Richard Torbett, chief executive of the Association of the British Pharmaceutical Industry (ABPI), told the committee’s MPs: “We need the bare minimum in order …

View Full Text

Log in

Log in through your institution


* For online subscription